Skip to main content

Advertisement

SpringerLink
Log in

The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Many genetic variations in the promoter region of tumor necrosis factor alpha (TNF-α) may confer host susceptibility to cancer by influencing TNF-α expression. Nevertheless, the results remain inconclusive. The current meta-analysis was performed to investigate the association between three common TNF-α promoter polymorphisms and the risk of non-Hodgkin lymphoma (NHL). A literature search was conducted mainly from PubMed for all eligible studies. The pooled odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) were used to assess the association of TNF-α polymorphisms with the risk of NHL. TNF-α −308 A allele showed a statistically significant increased risk for NHL under the homozygous (AA vs. GG, OR = 1.51, 95 % CI = 1.26–1.80) and recessive (OR = 1.47, 95 % CI = 1.23–1.75) models, respectively. The stratified analyses showed an increased risk of NHL with the presence of TNF-α −308 A allele among Africans and Caucasians, but a decreased risk among Asians. No association was observed between −238 G/A polymorphism and NHL risk either in the overall analysis or in the stratified analysis. Similarly, pooled analysis did not reveal an altered risk of NHL with −857 C/T polymorphism. Nonetheless, a statistically significant association was observed among Asians when stratified by ethnicity. Among the three genetic variations of interest, TNF-α −308 G/A polymorphism was significantly associated with the risk of NHL; neither −238 G/A nor −857 C/T polymorphism was shown to alter the overall NHL risk; however, stratified analysis by ethnicity observed a statistically significant association between −857 C/T polymorphism and the risk of NHL among Asians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Reference

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    PubMed  Google Scholar 

  2. Fears SSDaT (1992) Non-Hodgkin’s lymphoma time trends: United States and international data.

  3. Cartwright R, Brincker H, Carli PM, Clayden D, Coebergh JW, et al. The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer. 1999;35:627–33.

    CAS  PubMed  Google Scholar 

  4. K. N. Naresh VSCSS (2000) Distribution of various subtypes of non-Hodgkin’s lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO classifications.

  5. Smedby KE, Hjalgrim H. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol. 2011;21:293–8.

    PubMed  Google Scholar 

  6. Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:405–8.

    CAS  PubMed  Google Scholar 

  7. Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:2551–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, et al. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood. 2009;114:630–7.

    PubMed  Google Scholar 

  9. Balkwill F (2002) Tumor necrosis factor or tumor promoting factor?

  10. Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, et al. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents. 1992;6:103–7.

    CAS  PubMed  Google Scholar 

  11. Warzocha K, Salles G, Bienvenu J, Bastion Y, Dumontet C, et al. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol. 1997;15:499–508.

    CAS  PubMed  Google Scholar 

  12. Warzocha K, Salles G, Bienvenu J, Barbier Y, Bastion Y, et al. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas. Leukemia. 1997;11 Suppl 3:441–3.

    PubMed  Google Scholar 

  13. Li D, Li G, Wang B. Serum tumor necrosis factor-alpha levels in non-Hodgkin’s lymphoma patients and its relationship to prognosis. Zhonghua Zhong Liu Za Zhi. 1997;19:293–6.

    CAS  PubMed  Google Scholar 

  14. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood. 1998;91:3574–81.

    CAS  PubMed  Google Scholar 

  15. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997;94:3195–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998;51:605–12.

    CAS  PubMed  Google Scholar 

  17. Demeter J, Porzsolt F, Ramisch S, Schmid M, Messer G. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in hairy cell leukaemia. Br J Haematol. 1997;97:132–4.

    CAS  PubMed  Google Scholar 

  18. Chouchane L, Ahmed SB, Baccouche S, Remadi S. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer. 1997;80:1489–96.

    CAS  PubMed  Google Scholar 

  19. Demeter J, Porzsolt F, Ramisch S, Schmidt D, Schmid M, et al. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. Br J Haematol. 1997;97:107–12.

    CAS  PubMed  Google Scholar 

  20. Fitzgibbon J, Grenzelias D, Matthews J, Lister TA, Gupta RK. Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br J Haematol. 1999;107:388–91.

    CAS  PubMed  Google Scholar 

  21. Wihlborg C, Sjoberg J, Intaglietta M, Axdorph U, Pisa EK, et al. Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin’s disease and chronic lymphocytic leukaemia. Br J Haematol. 1999;104:346–9.

    CAS  PubMed  Google Scholar 

  22. Tsukasaki K, Miller CW, Kubota T, Takeuchi S, Fujimoto T, et al. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res. 2001;61:3770–4.

    CAS  PubMed  Google Scholar 

  23. Bogunia-Kubik K, Mazur G, Urbanowicz I, Wrobel T, Kuliczkowski K, et al. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia. Int J Immunogenet. 2005;33:21–4.

    Google Scholar 

  24. Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, et al. A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol. 2005;100:2644–9.

    CAS  PubMed  Google Scholar 

  25. Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006;107:4101–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 2006;66:9771–80.

    CAS  PubMed  Google Scholar 

  27. Bel Hadj Jrad B, Chatti A, Laatiri A, Ahmed SB, Romdhane A, et al. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin’s lymphomas. Eur J Haematol. 2007;78:117–22.

    PubMed  Google Scholar 

  28. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin lymphoma study. Carcinogenesis. 2007;28:704–12.

    CAS  PubMed  Google Scholar 

  29. Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, et al. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev. 2008;17:3161–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Jevtovic-Stoimenov T, Kocic G, Pavlovic D, Macukanovic-Golubovic L, Marjanovic G, et al. Polymorphisms of tumor-necrosis factor-alpha −308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk Lymphoma. 2008;49:2163–9.

    PubMed  Google Scholar 

  31. Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, et al. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin’s lymphoma. J Acquir Immune Defic Syndr. 2009;52:170–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83:334–42.

    CAS  PubMed  Google Scholar 

  33. Fernberg P, Chang ET, Duvefelt K, Hjalgrim H, Eloranta S, et al. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2010;21:759–69.

    PubMed  Google Scholar 

  34. Thunberg U, Enblad G, Turesson I, Berglund M. Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients. Leuk Lymphoma. 2010;51:1563–6.

    PubMed  Google Scholar 

  35. Xiao H, Zhang K. Genetic polymorphisms of tumor necrosis factor-alpha and lymphotoxin-alpha in Chinese patients with non-Hodgkin lymphoma. Ann Hematol. 2010;90:725–7.

    PubMed  Google Scholar 

  36. Ibrahim A, Abdel Rahman H, Khorshied M, Sami R, Nasr N, et al. Tumor necrosis factor alpha−308 and lymphotoxin alpha + 252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res. 2011;36:694–8.

    PubMed  Google Scholar 

  37. Bi X, Zheng T, Lan Q, Xu Z, Chen Y, et al. Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol. 2012;87:766–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Hosgood 3rd HD, Au WY, Kim HN, Liu J, Hu W, et al. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations. Int J Hematol. 2013;97:793–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Lech-Maranda E, Mlynarski W, Grzybowska-Izydorczyk O, Borowiec M, Pastorczak A, et al. Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia. Genes Chromosom Cancer. 2013;52:287–96.

    CAS  PubMed  Google Scholar 

  40. Liu J, Song B, Wang T, Liu Y, Hao J, et al. Genetic variations in CTLA-4, TNF-alpha, and LTA and susceptibility to T-cell lymphoma in a Chinese population. Cancer Epidemiol. 2013;37:930–4.

    PubMed  Google Scholar 

  41. Nasiri H, Farajnia S, Rezamand A, Movassaghpour AA, Esmaeili HA, et al. Genetic variations of tumor necrosis factor -alpha−308 and lymphotoxin-alpha + 252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients. Iran J Basic Med Sci. 2013;16:990–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Yri OE, Ekstrom PO, Hilden V, Gaudernack G, Liestol K, et al. Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab. Leuk Lymphoma. 2013;54:2205–14.

    CAS  PubMed  Google Scholar 

  43. Swartz MK. The PRISMA statement: a guideline for systematic reviews and meta-analyses. J Pediatr Health Care. 2011;25:1–2.

    PubMed  Google Scholar 

  44. Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res. 2007;67:5042–54.

    CAS  PubMed  Google Scholar 

  45. Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood. 2008;112:5150–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, et al. Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia. 2010;24:1055–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Chen Y, Zheng T, Lan Q, Foss F, Kim C, et al. Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood. 2011;117:585–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Mainou-Fowler T, Dickinson AM, Taylor PR, Mounter P, Jack F, et al. Tumour necrosis factor gene polymorphisms in lymphoproliferative disease. Leuk Lymphoma. 2000;38:547–52.

    CAS  PubMed  Google Scholar 

  49. Spink CF, Keen LJ, Mensah FK, Law GR, Bidwell JL, et al. Association between non-Hodgkin lymphoma and haplotypes in the TNF region. Br J Haematol. 2006;133:293–300.

    CAS  PubMed  Google Scholar 

  50. Habermann TM, Wang SS, Maurer MJ, Morton LM, Lynch CF, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Blood. 2008;112:2694–702.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. McAulay KA, Haque T, Crawford DH. Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. Br J Cancer. 2009;101:1019–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 2006;7:27–38.

    CAS  PubMed  Google Scholar 

  53. Au WY, Fung A, Wong KF, Chan CH, Liang R. Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leuk Lymphoma. 2006;47:2189–93.

    CAS  PubMed  Google Scholar 

  54. Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, et al. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation. 2007;84:387–91.

    PubMed  Google Scholar 

  55. Takashiba S, Shapira L, Amar S, Van Dyke TE. Cloning and characterization of human TNFα promoter region. Gene. 1993;131:307–8.

    CAS  PubMed  Google Scholar 

  56. Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409–16.

    CAS  PubMed  Google Scholar 

  57. Ding B, Fu S, Wang M, Yue C, Wang W, et al. Tumor necrosis factor alpha −308 G>A polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer. 2012;22:213–9.

    PubMed  Google Scholar 

  58. Zhang HL, Zhang YJ. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer. Tumour Biol. 2013;34:1659–65.

    CAS  PubMed  Google Scholar 

  59. Hong Y, Ge Z, Jing C, Shi J, Dong X, et al. Functional promoter −308G>A variant in tumor necrosis factor alpha gene is associated with risk and progression of gastric cancer in a Chinese population. PLoS ONE. 2013;8:e50856.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Fang F, Yao L, Yu XJ, Yu L, Wu Q. TNFalpha −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Res Treat. 2010;122:267–71.

    CAS  PubMed  Google Scholar 

  61. Xie L, Liang XN, Deng Y, Qin X, Li S. TNF-alpha-308G/A polymorphisms and nasopharyngeal cancer risk: a meta-analysis. Eur Arch Otorhinolaryngol. 2013;270:1667–72.

    PubMed  Google Scholar 

  62. Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, et al. Role of tumour necrosis factor gene polymorphisms (−308 and −238) in breast cancer susceptibility and severity. Breast Cancer Res. 2004;6:R395–400.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Gorouhi F, Islami F, Bahrami H, Kamangar F. Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer. 2008;98:1443–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Zhou P, Lv GQ, Wang JZ, Li CW, Du LF, et al. The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS ONE. 2011;6:e22092.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Yu JY, Li L, Ma H, Liu K, Cheng X, et al. Tumor necrosis factor-alpha 238 G/A polymorphism and gastric cancer risk: a meta-analysis. Tumour Biol. 2013;34:3859–63.

    CAS  PubMed  Google Scholar 

  66. Cheng K, Zhao YJ, Liu L, Wan JJ. Tumor necrosis factor-alpha 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis. Asian Pac J Cancer Prev. 2013;14:3275–9.

    PubMed  Google Scholar 

  67. Cen G, Wu W. Association between tumor necrosis factor-alpha 857C/T polymorphism and gastric cancer: a meta-analysis. Tumour Biol. 2013;34:3383–8.

    CAS  PubMed  Google Scholar 

  68. Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet. 2010;42:661–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet. 2011;7:e1001378.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Tan DE, Foo JN, Bei JX, Chang J, Peng R, et al. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet. 2013;45:804–7.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the National Science Fund for Distinguished Young Scholars (Grant No. 81325018), the key project for International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 81220108022), and Special Financial Grant from the China Postdoctoral Science Foundation (Grant No. 2014T70836).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. State Key Laboratory of Oncology in South China, Department of Experimental Research, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China

    Yong-Qiao He, Shao-Yi Huang, Jing He & Wei-Hua Jia

  2. Molecular Epidemiology Laboratory and Laboratory Medicine, Harbin Medical University Cancer Hospital, Harbin, 150040, Heilongjiang, China

    Jin-Hong Zhu

  3. Department of Statistics, University of California, Berkeley, CA, 94702, USA

    Zhuo Cui

Authors
  1. Yong-Qiao He
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin-Hong Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shao-Yi Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhuo Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jing He
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wei-Hua Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jing He or Wei-Hua Jia.

Additional information

Yong-Qiao He and Jin-Hong Zhu contribute equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, YQ., Zhu, JH., Huang, SY. et al. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis. Tumor Biol. 35, 12509–12517 (2014). https://doi.org/10.1007/s13277-014-2569-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2569-6

Keywords

Search

Navigation